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ABSTRACT 
 Nucleotide excision repair (NER) removes the major UV photolesions from cellular 
DNA. In humans, compromised NER activity is the cause of several photosensitive diseases, 
one of which is the skin-cancer predisposition disorder, xeroderma pigmentosum (XP). Two 
assays commonly used in measurement of NER activity are 'Unscheduled DNA synthesis 
(UDS)', and 'Recovery of RNA synthesis (RRS)', the latter being a specific measure of the 
transcription-coupled repair sub-pathway of NER. Both assays are key techniques for research 
in NER as well as in diagnoses of NER-related disorders. Until very recently, reliable methods 
for these assays involved measurements of incorporation of radio-labeled nucleosides. We have 
established non-radioactive procedures for determining UDS and RRS levels by incorporation 
of recently-developed alkyne-conjugated nucleoside analogues, 5-ethynyl-2'-deoxyuridine 
(EdU) and 5-ethynyuridine (EU). EdU and EU are respectively used as alternatives for 3H-
thymidine in UDS and for 3H-uridine in RRS. Based on these alkyne-nucleosides and an 
integrated image analyser, we have developed a semi-automated assay system for NER-
activity. We demonstrate the utility of this system for NER-activity assessments of 
lymphoblastoid samples as well as primary fibroblasts. Potential use of the system for large-
scale siRNA screening for novel NER defects as well as for routine XP diagnosis are also 
considered.   
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1. Introduction 
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 Genetic information stored in DNA is continuously threatened by various types of DNA 
damaging activity. A failure of DNA repair in living cells induces genomic instability, and may 
eventually result in cancer and other pathological consequences [1]. 
 Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are autosomal recessive 
photosensitive genodermatoses. XP patients show sunlight-induced pigmentation changes and 
skin-cancer predisposition, and in some cases neurological degeneration and mental 
retardation. CS patients are not susceptible to skin carcinogenesis, but, in addition to sun 
sensitivity, they show dwarfism, severe mental retardation, microcephaly, developmental 
disorders, and premature aging [2-4]. Most XP and all CS cases are associated with a 
deficiency in nucleotide excision repair (NER), which deals with major UV-photolesions as 
well as many chemical DNA adducts [5, 6]. There are two sub-pathways of NER. Global 
genome repair (GGR) is a relatively slow process that removes damage throughout the 
genome. Transcription-coupled repair (TCR) is a more rapid process that removes damage 
specifically from the transcribed strand of genes that are being actively transcribed. 
  
 
XP results from defects in one of eight genes, XPA through G and variant, whereas two genes, 
CSA and CSB, are responsible for CS. The XP A-G proteins are involved in different steps of 
NER. Recognition of the damage in GGR is mediated by the XPE and XPC proteins. The next 
step is opening out of the damaged region of DNA by TFIIH, which contains the XPD and 
XPB proteins and utilizes the helicase activity of XPD and the ATPase activity of XPB. After 
verification of the damage by XPA, the DNA is cleaved on the 5’ side of the damage by XPF 
and its partner protein ERCC1, and on the 3’ side by XPG. The damaged section is then 
removed and replaced by DNA polymerases, ligases and their accessory proteins.  
 
TCR differs from GGR in the initial damage recognition stage. In TCR, stalling of the RNA 
polymerase at the lesion is the initiating signal, and results in recruitment of the CSB and CSA 
proteins. The role of these proteins is to recruit the later NER proteins and various chromatin 
remodeling proteins to allow the subsequent steps of NER to take place. The roles of TFIIH, 
XPA, F and G are the same in TCR and GGR. Thus CS is associated with specific defects in 
TCR, whereas XP patients are defective in GGR alone (XPC and E) or in both GGR and TCR. 
 
Trichothiodystrophy (TTD) is a third disorder associated, in about 50% of cases, with defects 
in NER. In these cases, most are defective in XPD, a few in XPB and a few in a third gene 
TTDA. The products of these three genes are all components of TFIIH, which has independent 
roles in NER and in transcription. It is thought that mutations affecting the NER function result 
in XP, whereas those affecting transcription as well result in TTD. A few patients in the XPB, 
D and G groups have the combined features of XP and CS. 
 
Diagnosis of NER-related-disorders as well as NER research typically involves determining 
the level of nucleotide incorporation associated with DNA repair activity [7, 8].  GGR 
contributes 90-95% of NER and can be assessed by damage-induced, non–S-phase, DNA 
repair synthesis activity, termed unscheduled DNA synthesis (UDS) [7]. Patients with XP 
(except for the variant form, which is deficient in the translesion synthesis DNA polymerase, 
polη [10]),  XP combined with CS (XP/CS), and NER-deficient TTD, are GGR-defective and 
can be diagnosed by determining UDS levels. TCR can be readily measured by 'recovery of 
RNA synthesis (RRS)' levels after DNA damaging treatment. UV irradiation results in a 
decrease in RNA synthesis rates, which recover rapidly in normal cells, largely as a 
consequence of TCR [8]. In CS cells, which lack TCR, RNA synthesis does not recover and 
remains at a low level. 
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 In XP-diagnostic laboratories, 254nm UVC-irradiation is commonly used for inducing 
DNA damage; radio-labeled nucleosides, 3H-thymidine and 3H-uridine, have been generally 
used to measure UDS and RRS respectively [7, 8]. In both these assays, nuclear silver grain 
counting following autoradiography has been established as an accurate and sensitive but time-
consuming and laborious technique, while direct liquid scintillation counting of acid-insoluble 
DNA or RNA is a quicker but less quantitative method [12].  
 We have recently described a non-radioactive method for UDS measurement that 
entails incorporation of an alkyne-conjugated thymidine analogue, 5-ethynyl-2'-deoxyuridine 
(EdU) [13], in combination with a direct fluorescent azide coupling reaction using 
commercially available reagents (Invitrogen) [14]. This method provides a rapid and accurate 
alternative to the autoradiography-based assay; however, the method has so far been limited to 
determining GGR-activity and XP diagnosis as, until very recently, only a deoxy- form of the 
alkyne-nucleosides was available. Although this procedure obviates the need for labor-
intensive autoradiographic procedures, our published procedure still uses manual analyses of 
individual coverslips, which is a potential disadvantage for routine diagnoses or screening-
based operations. 
 Here we report the development of a semi-automated assay system for NER activity 
that is applicable to both UDS and RRS measurements using EdU  and the more recently 
available 5-ethynyluridine (EU) [15] . The EU-based RRS assay complements our recently 
reported EdU-based UDS assay. We have employed improved protocols suitable for plastic 96-
well plates and GE's 'In-Cell-Analyzer' – an automated plate scanner equipped with a 
fluorescent microscope and a CCD camera. We demonstrate that the technique is compatible 
with lymphoblastoid samples and is also applicable to large-scale siRNA screening projects. 
 
 
 
2. Materials and methods 
2.1. Cell strains and cultures 
 Normal 1BR [16] and 48BR [16], XP-patient-derived XP12BR (XP-D) [13], XP15BR 
(XP-A) [17], XP13BR (XP-C) [13], XP21BR (XP-C, this study) and XP20BE (XP-G) [18], 
and CS-patient-derived CS16PV (CS-A, Miria Stefanini, personal communication), CS20PV 
(CS-B, Miria Stefanini, personal communication) and CS10LO (CS-B) [19] cells were human 
primary fibroblasts. Normal 277 and 701 (both purchased from RIKEN), and XP-patient-
derived XPL5 (XP-V) [20] and XPL15OS (XP-A) [20] are EBV-immortalised B-
lymphoblastoids (LCLs). Fibroblasts and LCLs were cultured in respectively Dulbecco's 
Modified Eagle Medium (DMEM) and RPMI1640, both supplemented with 10% fetal calf 
serum (FCS) (Gibco-BRL) and penicillin-streptomycin (Wako). 
 
2.2. UDS assay with incorporation of ethynyldeoxyuridine (EdU) and automation using the In-
Cell-Analyzer 
 5-ethynyl-2'-deoxyuridine (EdU) is available from Invitrogen [14]. To optimise UV-
induced UDS by EdU incorporation and its measurement in microtiter plates with the In-Cell-
Analyzer, effects of UV-dose, EdU concentration and incubation period, fluorodeoxyuridine 
(FdU), and fixation, permeabilisation and staining conditions were examined. 48BR cells were 
plated at confluent density in 96-well plastic microtiter plates (Falcon) and cultured for 16h in 
DMEM supplemented with 10% FCS. Cells were washed with PBS, followed by irradiation 
with a range of doses (5~40 J/m2) of UVC (254nm, 50μW/cm2). After UV-irradiation, cells 
were immediately incubated for different time periods (0.5~4 h) in serum-free DMEM 
supplemented with various concentrations of EdU (2.5~20μM), and additionally supplemented 
with or without 1μM FdU (SIGMA). Serum-free medium was used as serum often contains 
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thymidine, which competes with EdU for incorporation into DNA. Cells were then washed 
with PBS, followed by fixation and permeabilisation. We examined two different fixation 
protocols: for 1-step fixation, cells were fixed and permeabilised in PBS containing 2% 
paraformaldehyde, 0.5% triton X-100, and 300mM sucrose for 20min on ice; for 2-step 
fixation, cells were fixed for 10min on ice with PBS containing 3.7% paraformaldehyde, 
followed by permeabilisation with 0.5% triton X-100 in PBS for 5min on ice. After extensive 
washing with PBS, cells were blocked for 30 min with 10% FCS in PBS at room temperature. 
To diminish background signal, we established the following improved azide-coupling staining 
protocol. Cells were incubated for 1h with 25 μM Alexa Fluor 488 azide (Invitrogen) in 
freshly-prepared 50mM Tris-HCl / 25mM NaCl (TBS) (pH 7.3), supplemented with 4mM 
CuSO4 and 10mM sodium ascorbate, followed by extensive washing with PBST (0.05% 
Tween20). Cells were then incubated with 20ng/ml DAPI in PBS for 20 min, and twice washed 
with PBST, followed by fixation in PBS containing 3.7% paraformaldehyde for 20min. 
 We found that 20J/m2 UVC-irradiation, followed by 5μM EdU incubation for 4h 
without FdU supplement, and the 1-step fixation protocol was the optimal condition for the 
UDS assay on plastic 96-well plates. This condition was used for all experiments unless 
otherwise stated. 
 Image acquisition and data processing were automated using GE's In-Cell-Analyzer 
system: plates were scanned with a CCD-camera-equipped scanning microscope, and captured 
images were directly processed using the automated Developer software programmed for 
detection of nuclei (DAPI staining), measurements of the fluorescent intensity (Alexa Fluor 
488 staining), and subtraction of background signals calculated from the fluorescent intensity 
of circumference of nuclei. All non-S-phase cells in a single captured field (60~70 cells) were 
evaluated, and the median fluorescence density values of discrete nuclei were calculated from 
the pixels contained in each nucleus. Data points presented in the figures are the averages 
calculated from ten different fields. Developer Toolbox scripts describing the assay protocols 
are available from the authors. 
  
2.3. Non-radioactive RRS assay by incorporation of ethynyluridine (EU) using the In-Cell-
Analyzer 
 5-ethynyluridine (EU) is available from Invitrogen [15]. To optimize RRS 
measurement by EU incorporation using plastic plates and the In-Cell-Analyzer, we again 
analysed the effects of various parameters. 48BR cells were plated at confluent density on 96-
well plastic microtiter plates and cultured for 16h in DMEM supplemented with 10% FCS. 
Cells were washed with PBS, followed by irradiation with a range of doses (5~20 J/m2) of 
UVC. After UV-irradiation, cells were incubated for different time periods (0~24 h) for RNA 
synthesis recovery in DMEM supplemented with 1% FCS. Cells were then immediately 
incubated for different time periods (0.5~4 h) in serum-free DMEM supplemented with various 
concentrations of EU (50~1000μM). Cells were then washed with PBS, followed by fixation 
and permeabilisation by the two different protocols, and azide-coupling reaction and DAPI 
staining as described above. 
 We found that 5J/m2 UVC-irradiation, followed by 4h incubation for RNA synthesis 
recovery and 2h labeling in media supplemented with 100μM EU, and the 1-step fixation 
protocol was the optimal condition for the RRS assay on plastic 96-well plates. This condition 
was used for all experiments unless otherwise stated. 
 Image acquisition and data processing were automated using the In-Cell-Analyzer and 
the Developer software as described above. All cells in a single captured field were evaluated, 
and the median fluorescence density values of discrete nuclei were calculated from the pixels 
contained in each nucleus. Data points presented in the text are the averages calculated from 
ten different fields. 
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2.4. EdU-based UDS assay on lymphoblastoid samples 
 EBV-immortalised lymphoblastoid cells (LCLs) were cultured in RPMI1640 
supplemented with 1% FCS (low-serum media) for 72h prior to the experiments. This step is 
needed to minimise the number of cells in S-phase as DNA replicative synthesis significantly 
interferes with UDS signals in LCL samples. We tried different UV-doses (5~20J/m2), EdU 
concentrations (5~10μM) and incubation time-periods (1~4h), and fixation and 
permeabilisation protocols (data not shown), and found that the following condition is optimal 
for the UDS assay for LCL samples. Cells were centrifuged, suspended in PBS and UVC 
irradiated (20 J/m2) in non-tissue-culture-treated plastic dishes, followed by 1h incubation in 
serum-free RPMI1640 supplemented with 10 μM EdU. After washing with PBS, cells were 
fixed and permeabilised in PBS containing 2% paraformaldehyde, 0.5% triton X-100, and 
300mM sucrose for 20 min on ice. Cells were then blocked for 30 min with 10% FCS in PBS 
at room temperature. Azide-coupling and DAPI staining were performed as described above, 
but all done in eppendorf tubes and 0.5mM EDTA was included in all steps after the azide-
coupling reaction. Processed cells were finally suspended in PBS supplemented with 0.5mM 
EDTA, followed by cytospin-centrifugation at 1500 rpm for 2min using multi-chamber 
cytofunnels (Thermo). Image acquisition and data processing were automated using the In-
Cell-Analyzer system as described above.  
 
2.5. RNA interference 
 Pre-designed siRNA oligos targeting for XP- and non-NER-related repair genes, and 
scrambled non-targeting controls were the MISSION siRNA purchased from SIGMA (the 
siRNA oligo sequences can be obtained from the authors upon request). siRNA transfection 
was performed using Xtream gene (Roche) transfection reagent according to the 
manufacturer’s instruction. 10nM of siRNA oligos were transfected in suspension, followed by 
one additional transfection cycle 24 h after the first transfection. UDS and RRS assays were 
performed 48 h after the first siRNA transfection. Knockdown efficiencies were confirmed by 
western blot. 
 
3. Results 
3.1. Development of an automated EdU-based UDS assay system using the In-Cell-
Analyzer 
 We first optimised the EdU-based UDS assay conditions for the automated system 
(Figure 1A). 48BR normal human primary fibroblasts were seeded into 96-well plates. Cells 
were then UVC (245nm) irradiated with a range of doses, followed by incubation for different 
time periods with serum-free media containing various concentrations of EdU, with or without 
the thymidylate synthetase inhibitor, fluorodeoxyuridine (FdU) (Figure 1B-1E). Incorporated 
EdU was detected by the Alexa Fluor 488-azide coupling reaction using a modified coupling-
buffer after permeabilisation of the cells using two different protocols (details described in 
Materials and Methods). 96-well plates were then processed by the In-Cell-Analyzer. We were 
able to detect DNA damage-dependent EdU incorporation, which denotes UDS activity, in 
fibroblasts cultured on plastic-96 well-plates, as previously observed in coverslip-based 
experiments (Figure 1B). DAPI staining clearly enabled the detection of nuclei, which is 
needed for cell-cycle determination as well as for the automated nuclear fluorescent 
measurements (Figures 1A, 1B); though we noted that the background fluorescent intensity 
was relatively higher than in the coverslip-based assay (data not shown), an appropriate 
background subtraction process, which is also a feature of the software (details described in 
Materials and Methods, Figure 1A), clearly diminished interference of unwanted fluorescent 
signals inside the nuclei (data not shown). We found that the EdU concentration did not 
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significantly affect the UDS-specific nuclear fluorescent intensity levels over the range 
examined (Figure 1C). A supplement of FdU contributed only slightly to the UDS specific EdU 
incorporation, whereas the permeabilisation processes significantly affected the fluorescent 
intensity (Figure 1D). As we previously demonstrated [13], UDS dependent EdU incorporation 
was increased in proportion to UV dose and incubation time period (Figure 1E). We found that 
10-20 J/m2 UVC irradiation, 5μM EdU for 4h labeling, and the one-step fix and 
permeabilisation process, are the optimum conditions for the EdU assay with the automated 
system. 
 
3.2. Rapid assessment of GGR-deficiency in XP cells by the semi-automated UDS assay 
 We next assessed the UDS levels of several NER-deficient fibroblasts and normal 
controls. To evaluate the reproducibility and variation of the UDS levels assayed in plastic 96-
well-plates, each cell line was plated in quintuplicate and assayed as shown in Figure 2A. 
Satisfyingly, plate-to-plate variation (data not shown) as well as well-to-well variation were 
both very small (compare bars 1-5, and 8-12 in each panel), indicating that the assay is very 
reproducible. We noted that the UDS levels of normal fibroblasts from five different 
individuals assayed in this system varied between 96-102% of 48BR cells (Figure 2B, 2C, and 
data not shown); this variation was significantly smaller than that obtained with different 
assays based on cells plated on coverslips using either autoradiography or EdU incorporation 
[13]. We further determined the UDS levels of typical NER-deficient cell lines; as shown in 
Figure 2D-2G, severe NER-deficient XP cell lines, XP15BR (XP-A) and XP20BE (XP-G), 
showed no detectable UDS (Figure 2D,E), whereas intermediate NER-deficient XP12BR (XP-
D) and XP13BR (XP-C) cell lines elicited weak but statistically significant UDS activities 
(Figure 2F,G).  
 
As CS cells are only compromised in the TCR pathway of NER, a UDS deficiency has not 
been detected by conventional procedures. Figure 2H and Supplemental Figure S1 indicate 
modest but statistically significant UDS reductions in CS-A and CS-B cells, indicating that the 
automated system may be able to detect minor UDS-deficiencies because of improved 
objectivity and reproducibility. It may however transpire that, with a broader range of normal 
and CS cell-lines, these variable UDS reductions in CS cell-lines may in fact fall within the 
normal range; nevertheless, the system is at least sensitive enough to detect cell line-to-cell line 
UDS variations, consistently.  
 
The UDS levels that we have measured were in good agreement with the levels assayed by 
thymidine incorporation and with our EdU based measurements on coverslips (Supplemental 
Table S1) [13], indicating that the system provides a convenient, but sensitive and accurate 
assay for UDS. 
 
3.3. EU-based non-radioactive recovery of RNA synthesis (RRS) assay using In-Cell-
Analyzer 
 After our recent publication, we noticed that EU, which can be used for in vivo RNA 
labeling, had become commercially available (Invitrogen). We assumed that an EU based RRS 
assay might be a good alternative for the classical radioisotope based assays. As an EU based 
RNA labeling protocol has been recently published [15], we tested if EU incorporation could 
be used to detect the delay in RNA synthesis recovery typical of TCR-deficient CS fibroblasts, 
and whether it can be assessed on the automated system (scheme described in Figure 3A). In 
normal fibroblasts, we could detect EU incorporation-specific fluorescence signals over the EU 
concentration range we examined; this incorporation was significantly inhibited by UV 
irradiation (Figure 3B). Unlike in the case of EdU labeling, permeabilisation procedures did 
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not influence the fluorescence levels (data not shown). We found that, with our improved 
coupling protocol described in detail in Materials and Methods, a 2h labeling period with 
100μM EU was sufficient for RNA synthesis detection in normal 48BR cells without DNA 
damaging treatment (Figure 3C, 3D), even though the original publication noted that a higher 
EU concentration and longer incubation period are optimum for the EU labeling [15]. (We also 
noted that the EU labeling efficiency did not increase linearly with incubation time (Figure 
3D)). We then examined RNA synthesis recovery after UVC irradiation (Figure 3E). For CS 
diagnostic tests, a typical protocol measures RNA synthesis levels 16-24 h after irradiation of 
samples with different UV doses [21]. As shown in Figure 3E, using the automated EU assay, 
RNA synthesis recovers after a few hours in response to UV in normal fibroblasts, while in 
CS-B cells (CS10LO), no significant recovery was observed even 24h after irradiation with 
UV doses of 10 J/m2 and above. However, we decided to use 5 J/m2 UVC irradiation and 4h 
recovery for the RRS assay in the system, as the shorter recovery period diminishes the time 
needed for the assay, and this condition provided good discrimination between normal and CS 
cells. Although increased discrimination could be obtained with longer recovery times, we 
chose to use this short recovery protocol, so that we can complete a set of UDS and RRS 
assays in a single day. CS cell-lines were assayed using this system and statistically significant 
reductions in RRS were clearly detected, while almost complete RNA synthesis recovery was 
observed in normal fibroblasts (Figure 4A-4D, and Supplemental Figure S2). We also detected 
reduced recovery in TCR-defective XP-A (XP15BR) and XP-D (XP12BR) cells (Figure 4E, 
4F), while recovery in two XP-C cells, XP13BR (mild UDS-deficiency) and XP21BR (severe 
UDS-deficiency), which are compromised in GGR but not TCR, approached that in normal 
controls (Figure 4G, 4H). These results reflect those obtained with conventional assays (eg 
Mayne and Lehmann, 1982) and demonstrate that the EU-based RRS assay in conjunction with 
the In-Cell-Analyzer provides a convenient and accurate measurement of RNA synthesis 
recovery, and is suitable for rapid diagnoses of TCR-compromised disorders.  
 
3.4. Rapid UDS measurements for lymphoblastoid cells provided by the EdU-based assay 
 We further tested whether the EdU-based UDS assay might also be applicable to 
peripheral lymphocyte samples: lymphocyte-based diagnoses would be less invasive than 
existing assays that require fibroblasts from skin-biopsies. B-cell enriched lymphocytes can be 
prepared from whole-blood samples by use of immuno-magnetic-beads as well as Ficoll-based 
separation reagents. As a first step towards analyses using lymphocytes, we performed EdU-
based UDS assays on EBV-immortalised lymphoblastoid cell lines (LCLs) established from 
normal donors (277, and 701), and from XP-patients (XPL5, XP-V; XPL15OS, XP-A) using 
the experimental scheme shown in Figure 5A. LCLs were cultured for 72 h in low serum 
media to diminish the number of cells in S-phase. Cells were then UVC irradiated (20J/m2), 
followed by 1h incubation in serum-free medium supplemented with 10 μM EdU 
(experimental details described in Materials and Methods). UV-induced UDS was detected in 
normal 277 and 701 LCLs (Figure 5B, 5C), while no detectable UDS was observed in XP-A 
deficient XPL15OS (Figure 5D). As expected, we observed normal UDS levels in the XP 
variant XPL5 cells (Figure 5E). These results confirm that the EdU-based UDS assay might be 
applicable for XP diagnosis with clinical blood samples. 
 
3.5. A potential use of the automated system for large scale screens 
 A major advantage of using automated systems is that they can be used for large-scale 
screens. We considered if our set-up might be applicable to searching for novel genes in NER 
using an siRNA-based screen. To test the system, we designed a small-scale pilot experiment 
knocking-down XP and genes unrelated to NER using a set of siRNA oligos. 48BR cells were 
transfected with siRNA in 96-well plates, and UDS and RRS levels were measured by the 
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system (Figure 6A; details of RNA interference are described in Materials and Methods). As 
expected, we detected a reduction in UDS and RRS in the cells transfected with XP-targeting 
siRNAs, whereas it remained unchanged in cells transfected with either control siRNA or 
siRNAs against NER-unrelated genes (Figure 6B, 6C). Note that no attempt was made in this 
pilot study to optimize knock-down conditions. As siRNA-based gene targeting is often 
imperfect, screening systems have to be sensitive and reproducible enough to pick-up small 
changes in NER activity. Our system is sensitive enough to detect the effects of knocking-
down known XP genes, suggesting that it can be used for an extensive screen.  
 
 4. Discussion 
 The most commonly used techniques for UDS and RRS measurements involve 3H-
thymidine labeled nucleoside incorporation, followed by evaluation of silver-grain counting 
after autoradiography of tissue-culture coverslips [7]. Since it is both accurate and sensitive, 
this laborious technique has remained in vogue even after several alternative methods have 
been reported [12, 21-23]. Bromodeoxyuridine (BrdU) and bromouridine (BU) are respectively 
popular alternatives for DNA-labeling by 3H-thymidine and RNA-labeling by 3H-uridine. 
Nevertheless publications using BrdU for UDS and BU for RRS assays have been very limited 
due to their restricted sensitivity and resolution [22, 24]. Recently developed alkyne-
conjugated nucleoside analogues, EdU and EU, have been proved to be useful for S-phase 
DNA labeling and detection of nascent RNA synthesis, respectively [14, 15]; however it has 
not been clear whether labeling with these nucleoside analogues was sufficiently robust to 
enable their use in UDS and RRS. In our preceding report, we demonstrated that an EdU-based 
UDS assay is accurate enough to be an alternative to autoradiography [13]; the biggest 
improvements from employing EdU to the UDS assay are the obviation of the need to use 
radioactive materials, and of time-consuming and skilled procedures. We showed in our report, 
that the entire UDS assay can be completed within a day from preparation of the assay 
coverslips, and also that the method is compatible with standard cell-biology techniques such 
as immunofluorescent staining and labeling of cells with micro-latex beads, which are often 
used in combination with the UDS assay.  
 
 In this report, we firstly automated the UDS assay. This approach dramatically 
improved the sensitivity of the EdU-based method; the system achieved more than ~50% 
reduction of the background signals (Compare ref. 13 and Figure 2), which is now as good as 
the conventional autoradiographic technique [7]. The assay is sensitive and reproducible 
enough to distinguish between normal controls and TCR-deficient CS cells, as well as between 
severely UDS-deficient XP-A or XP-G cells and moderately deficient XP-D or XP-C cells 
(Figure 2B, 2C and 2H, and 2D-2G). Secondly, we adopted an RNA precursor, EU, which has 
recently become commercially available, for the RRS assay. The EU-based RRS assay is also 
suitable for use in the automated system. Both UDS and RRS levels can be measured in 96-
well plates as sensitively as using autoradiography. We finally evaluated the system for several 
applications. We showed that the EdU-based UDS assay is applicable to lymphoblast samples. 
Although the results are not as precise as with fibroblasts, this blood-sample-based approach 
may eventually benefit the patients as it obviates invasive skin-biopsies. 
 
 We also investigated the suitability of the system for large-scale screening. We designed 
a pilot siRNA screening experiment; it demonstrated that a micro-titer plate-based NER-
activity assay can be used for screening. The automated NER-assay system can process 
~twenty 96-well plates per day (In-Cell-Analyzer 1000).This enables the evaluation of both 
UDS and RRS activities of ~100 different samples to be carried out in a day, if the screening is 
performed using the format shown in Figures 2A and 4A. The above EdU or EU -based assays 
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can be transferred to a commonly used fluorescent microscope equipped with a motorised 
stage and focus, and a monochrome CCD camera. We have set up a system using a Zeiss 
microscope, Axio-Observer Z1, equipped with a long working distance lens, HRm 
monochrome CCD camera, and an ASI's motorised X-Y stage, MS-2000. Sequential image 
acquisition and analysis are performed automatically on a macro program running Axiovision 
software (the script is available from the authors). 
 The NER-deficiency assessments by incorporation measurements of EdU and EU have 
the potential to become standard techniques in basic NER research as well as in clinical 
diagnosis of NER related diseases. They also have the potential for use in chemotherapy, for 
example to measure NER in tumor cells to predict sensitivity to platinum-based therapy. 
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FIGURE LEGENDS 
Figure 1. EdU-based semi-automated UDS assay using the In-Cell-Analyzer. (A) An 
experimental scheme for the UDS assay. Cells were plated on plastic 96-well plates, UVC-
irradiated (254nm) with a range of doses (0~40 J/m2), followed by incubation for different time 
periods (0.5~4 h) in serum-free media supplemented with various concentrations of EdU 
(2.5~20μM), and additionally supplemented with or without 1μM FdU. Fixation (1- or 2-step), 
conjugation of Alexa Fluor 488-azide to the incorporated EdU, and nuclear DAPI staining are 
described in Materials and Methods. Image acquisition and data processing were automated 
using GE's In-Cell-Analyzer system. (B) Typical UDS images captured by the In-Cell-
Analyzer. Normal 48BR cells were cultured in 96-well plates and UVC irradiated (20 J/m2; 
+UV) or mock-treated (-UV), followed by 4h incubation with medium supplemented with 5 
μM EdU. Cells were processed as described in (A). Circles and dashed circles indicate non-S-
phase and S-phase cells, respectively. (C) Effects of EdU concentration: 48BR cells were UVC 
irradiated (20J/m2), followed by 4h incubation in media supplemented with various 
concentrations of EdU (2.5~20μM). Cells were processed as described in (A). (D) Effects of 
FdU and fixation process on the UDS assay. 48BR cells were UVC-irradiated (0~40J/m2), 
followed by 4h incubation in media supplemented with 10 μM EdU, and with or without 1μM 
FdU. Cells were then fixed with two different protocols. (E) Effects of UV dose and EdU 
incubation time-period for the UDS assay. 48BR cells were UVC irradiated at the indicated 
doses, followed by incubation in media supplemented with 5μM EdU for different time periods 
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(0.5~4h). Cells were processed as described in (A). Bars or data points, and error bars indicate 
average fluorescent intensity of discrete nuclei and standard errors, respectively. 
 
Figure 2. Reproducible detection of NER-activity by the UDS assay system. (A) The EdU-
based UDS assay on normal and NER-deficient fibroblasts was performed together in a single 
96-well plate. (B-H) The indicated human primary fibroblasts were seeded in a 96-well plate in 
quintuplicate as shown in (A). The assay plate was half-covered by a plastic-board wrapped in 
aluminum foil and UVC irradiated (closed bars, 20 J/m2; open bars, no-UV), followed by 4h 
incubation with media supplemented with 5μM EdU. Cells were then processed as described in 
Figure 1. Bars and error bars indicate averages of discrete nuclear fluorescence intensity and 
standard errors, respectively. Δ represents UDS difference between irradiated and unirradiated 
samples. Percentages indicate UDS levels normalised against 48BR. Student's t-test was 
performed to evaluate differences in UDS levels between cell lines: 48BR vs. 1BR, not 
significant (p=0.5); XP15BR vs. XP20BE, not significant (p=0.3); 48BR vs. CS10LO, 
CS10LO vs. XP12BR, XP15BR vs. XP13BR and XP12BR vs. XP13BR, significant (p<0.01).  
 
Figure 3. EU-based semi-automated RRS assay using In-Cell-Analyzer. (A) An experimental 
scheme of the RRS assay. Cells were plated on plastic 96-well plates, UVC-irradiated with a 
range of doses (0~20 J/m2), followed by incubation for different time periods (0~24 h) for 
RNA synthesis recovery in media supplemented with 1% FCS. Cells were then incubated for 
different time periods (0.5~4h) with serum-free media supplemented with various 
concentrations of EU (50~1000 μM). Incorporated EU was detected as described in Materials 
and Methods. Image acquisition and data processing were automated using the automated 
system. (B) Typical RNA synthesis images captured by the In-Cell-Analyzer. Normal 48BR 
cells were cultured in 96-well plates and UVC irradiated (5 J/m2; +UV) or mock-treated (-UV). 
Cells were then incubated for 2h for RNA labeling with serum-free media supplemented with 
100 μM EU. (C) Effect of EU concentration on RNA labeling. 48BR cells were incubated for 
2h in media supplemented with various concentrations of EU (50~1000μM). (D) Effect of 
incubation time on RNA labeling. 48BR cells were incubated for different time periods in 
media supplemented with 100 μM EU. (E) Effects of UV dose and RNA synthesis recovery 
time-period for the RRS assay. Normal 48BR (closed symbols) and CS-patient-derived 
CS10LO (open symbols) cells were UVC irradiated at the indicated doses (5~20 J/m2), 
followed by incubation for different time periods (0~24h) in media supplemented with 1% FCS 
to allow RNA synthesis recovery. Subsequently, RNA was labeled for 2h in a serum-free 
medium supplemented with 100 μM EU. 
 
Figure 4. EU-based semi-automated RRS assay distinguishes between GGR and TCR -
compromised XP cells. (A) EU-based RNA synthesis recovery assay on normal and NER-
deficient fibroblasts were performed at once in a single 96-well plate. (B-H) The indicated 
human primary fibroblasts were seeded into a 96-well plate in quintuplicate and UVC 
irradiated (closed bars, 5 J/m2; open bars, no-UV) as described in Figure 2. The cells were 
incubated for 4h in media supplemented with 1% FCS to allow RNA synthesis recovery, 
followed by RNA labeling for 2h in a serum-free medium supplemented with 100 μM EU. 
Cells were then processed as described in Figure3. Bars or data points, and error bars indicate 
averages of discrete nuclei fluorescent intensity and standard errors, respectively. RRS levels 
were normalised and expressed as percentages of the average RNA synthesis levels in 
unirradiated cells (red lines). Student's t-test was performed to evaluate differences in RRS 
levels between cell lines: 48BR vs. 1BR, not significant (p=0.2); XP13BR vs. XP21BR, not 
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significant (p=0.8); 48BR vs. CS10LO, 48BR vs. XP21BR and XP21BR vs. CS10LO, 
significant (p<0.01).  
 
Figure 5. UDS assayed in normal and XP-patient derived lymphoblastoid samples. (A) An 
experimental scheme of the UDS assay for lymphoblastoid samples. Lymphoblastoid cells 
were cultured for 72h in low-serum media to diminish the number of cells in S-phase. Cells 
were then UVC irradiated (20 J/m2), followed by 1h incubation in serum-free medium 
supplemented with 10 μM EdU. Cells were then fixed and permeabilised, and processed as 
detailed in Materials and Methods. The azide-coupling reaction was performed in eppendorf 
tubes. Processed cells were then cytospin-centrifuged, and images captured and analysed by 
the In-Cell-Analyzer. (B-E) Lymphoblastoid cells derived from normal, and XP-patients were 
assayed by the system. Histograms of the UDS assay with irradiated (closed bars) and 
unirradiated (open bars) cells are shown. 
 
Figure 6. A pilot experiment for prospective siRNA-screening performed by the automated 
system. (A) Experimental scheme of the siRNA transfection and subsequent NER-activity 
assayed by the automated system. (B, C) Cells were transfected with indicated siRNAs prior to 
UV irradiation, and NER-activity was measured as described in (A). (B) UDS activities in cells 
depleted for XP and NER-unrelated genes. UDS activity was normalised against samples 
which were transfected with non-targeting control siRNA. (C) RRS activities in cells depleted 
for XP genes. RNA synthesis recovery levels were normalised against the RNA synthesis 
levels in unirradiated cells. Error bars indicate standard errors of means of measurements in 
triplicate wells.  
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Supplemental Table S1. UDS levels measured by 3H-thymidine incorporation and EdU-
based assays 
 
 UDS levels (%)*1
Cell lines 3H-Thy incorporation*3 EdU incorporation 
  on coverslips*4 on 96-well plates 
normals*2 100 95 101 
XP15BR (XP-A) 0 7 1 
XP13BR (XP-C) 24 22 8 
XP12BR (XP-D) 40 42 26 
XP20BE (XP-G) <5%5 1 0 
*1Percentages indicate UDS levels normalised against 48BR. *2normals denotes averages of 
UDS levels measured in 2-4 different normal cell lines in each method. *3, *4Adapted from 
Limsirichaikul et al., Nucleic Acids Research, 37, e31 (2009), 5Data from ref 26.. 
 
Supplemental Figure S1. Detection of possible UDS reductions in CS-A and CS-B cells. (A-
C) The indicated human primary fibroblasts were seeded in a 96-well plate in quintuplicate as 
shown in Figure 2. The assay plate was half-covered by a plastic-board wrapped in aluminum 
foil and UVC irradiated (closed bars, 20 J/m2; open bars, no-UV), followed by 4h incubation 
with medium supplemented with 5μM EdU. Cells were then processed as described in Figure 
2. Bars and error bars indicate averages of discrete nuclear fluorescence intensity and standard 
errors, respectively. Δ represents UDS difference between irradiated and unirradiated samples. 
Percentages indicate UDS levels normalised against 48BR. Student's t-test was performed to 
evaluate differences in UDS levels between cell lines: 48BR vs. CS16PV, and CS16PV vs. 
CS20PV, significant (p<0.01). What about 48BR vs CS20PV? 
 
Supplemental Figure S2. Reduced RNA synthesis levels in CS-A and CS-B cells. (A-C) The 
indicated human primary fibroblasts were seeded into a 96-well plate in quintuplicate and 
UVC irradiated (closed bars, 5 J/m2; open bars, no-UV) as described in Figure 4. The cells 
were incubated for 4h in media supplemented with 1% FCS to allow RNA synthesis recovery, 
followed by RNA labeling for 2h in a serum-free medium supplemented with 100 μM EU. 
Cells were then processed as described in Figure 4. Bars and error bars indicate averages of 
fluorescent intensity of discrete nuclei and standard errors, respectively. RRS levels were 
normalised and expressed as percentages of the average RNA synthesis levels in unirradiated 
cells (red lines). Student's t-test was performed to evaluate differences in RRS levels between 
cell lines: 48BR vs. CS16PVO and CS16PV vs. CS20PV, significant (p<0.01). What about 
48BR vs CS20PV? 
 
 
 
 
 






